KAREN KLINE: Open Payments
NPI 1114548468 · BRADFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 27 payments from 14 companies in 2025. Trend: 2023 $1,050 · 2024 $691 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Alkermes, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lundbeck LLC | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Braeburn Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: COBENFY, Auvelity, Jornay PM, CAPLYTA, REXULTI, INGREZZA, BRIXADI, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
